Denmark vs Saudi Arabia: Access to anti-retroviral drugs, male
Denmark
93.0%
in 2023
Saudi Arabia
93.0%
in 2024
Denmark rank
7th
Saudi Arabia rank
7th
Access to anti-retroviral drugs, male over time
- Denmark
- Saudi Arabia
How they compare
Denmark currently reports 93.0% against 93.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 4 times across 24 shared years of data; in 2000 it was Denmark ahead.
Denmark ranks 7th and Saudi Arabia ranks 7th of 141 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.4% | 27.0% | 22.4% | Denmark |
| 2010s | 77.6% | 56.4% | 21.2% | Denmark |
| 2020s | 91.2% | 90.8% | 0.5% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Denmark or Saudi Arabia?
- Denmark, at 93.0% against 93.0% in Saudi Arabia as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Denmark and Saudi Arabia?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Saudi Arabia?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Saudi Arabia rank globally for access to anti-retroviral drugs, male?
- Denmark ranks 7th and Saudi Arabia ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.